|
|
|
Insider
Information: |
Eramian Daniel G |
Relationship: |
EVP, Corporate Communi... |
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
354,350 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,221,042 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
354,350 |
|
|
Total
Value |
$3,221,042 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Cti Biopharma Corporation |
CTIC |
EVP, Corporate Communi... |
2012-09-20 |
354,350 |
2006-03-31 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
29 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2006-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
40,000 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2006-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
55,000 |
|
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2007-09-25 |
4 |
A |
$0.00 |
$0 |
D/D |
70,563 |
84,313 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2007-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
120,000 |
204,313 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2008-10-22 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
95,431 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
868,967 |
964,398 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-07-31 |
4/A |
D |
$1.48 |
$347,895 |
D/D |
(235,064) |
1,374,231 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-07-31 |
4 |
D |
$1.48 |
$347,895 |
D/D |
(235,064) |
964,398 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
644,897 |
1,609,295 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-09-25 |
4 |
S |
$1.25 |
$130,345 |
D/D |
(104,276) |
1,269,955 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-10-22 |
4 |
D |
$1.11 |
$30,344 |
D/D |
(27,337) |
1,242,618 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
870,050 |
2,112,668 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-11-10 |
4 |
D |
$0.99 |
$313,962 |
D/D |
(317,133) |
1,795,535 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2009-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,040) |
1,790,495 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2010-03-25 |
4 |
D |
$0.67 |
$70,738 |
D/D |
(105,579) |
1,684,916 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2010-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
2,989,983 |
4,674,899 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2010-12-16 |
4 |
S |
$0.36 |
$90,000 |
D/D |
(250,000) |
4,424,899 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2010-12-27 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,000) |
4,416,899 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2011-03-21 |
4/A |
A |
$0.00 |
$0 |
D/D |
250,000 |
4,666,899 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2011-03-25 |
4 |
D |
$0.38 |
$40,120 |
D/D |
(105,579) |
4,311,320 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2011-09-21 |
4 |
D |
$1.02 |
$7,745 |
D/D |
(7,593) |
752,627 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communication |
|
2011-11-29 |
4 |
A |
$0.00 |
$0 |
D/D |
505,688 |
1,258,315 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2011-12-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(498,329) |
759,986 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,211,953 |
1,971,939 |
0 |
- |
|
CTIC |
Cti Biopharma Corporation |
EVP, Corporate Communications |
|
2012-03-21 |
4 |
D |
$1.31 |
$9,947 |
D/D |
(7,593) |
1,964,346 |
0 |
- |
|
29 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|